Decreased body mass index during treatment with sodium oxybate in narcolepsy type 1
Open Access
- 4 March 2018
- journal article
- research article
- Published by Wiley in Journal of Sleep Research
- Vol. 28 (3) , e12684
Abstract
Summary: Narcolepsy type 1 is characterised by an increase in body weight after disease onset, frequently leading to obesity. It was suggested that this weight gain may be counteracted by treatment with sodium oxybate. We here provide longitudinal body mass index data of patients with narcolepsy type 1 after starting treatment with sodium oxybate, compared with patients in whom treatment with modafinil was initiated. Eighty‐one individuals with narcolepsy type 1 fulfilled the entry criteria for this retrospective study: 59 had newly started treatment with sodium oxybate and 22 had newly started modafinil. Gender‐specific differences between both treatment groups were compared using Student's t tests and mixed effect modeling. Patients using sodium oxybate lost weight, with a mean body mass index decrease of 2.56 kg/m2 between the first and last measurement (women; p = .001) and 0.84 kg/m2 (men; p = .006). Patients using modafinil, however, gained weight, with a mean body mass index increase of 0.57 kg/m2 (women; p = .033) and 0.67 kg/m2 (men; p = .122). Medication (p = .006) and baseline body mass index (p = .032) were predictors for body mass index decrease. In conclusion, treatment with sodium oxybate is associated with a body mass index reduction in narcolepsy type 1, whereas modafinil treatment is not. This effect is most pronounced in those who already have a higher baseline body mass index.Keywords
This publication has 26 references indexed in Scilit:
- Plasma Total Ghrelin and Leptin Levels in Human Narcolepsy and Matched Healthy Controls: Basal Concentrations and Response to Sodium OxybateJournal of Clinical Sleep Medicine, 2013
- Effect of sodium oxybate on growth hormone secretion in narcolepsy patients and healthy controlsAmerican Journal of Physiology-Endocrinology and Metabolism, 2011
- Weight loss in narcolepsy patients treated with sodium oxybateSleep Medicine, 2009
- IS ALCOHOL CONSUMPTION A RISK FACTOR FOR WEIGHT GAIN AND OBESITY?Critical Reviews in Clinical Laboratory Sciences, 2005
- Weight Gain During Long-Term Treatment of Obsessive-Compulsive DisorderThe Journal of Clinical Psychiatry, 2004
- Lipid metabolism in womenProceedings of the Nutrition Society, 2004
- To Eat or to Sleep? Orexin in the Regulation of Feeding and WakefulnessAnnual Review of Neuroscience, 2001
- A randomized trial of the long-term, continued efficacy and safety of modafinil in narcolepsySleep Medicine, 2000
- Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsyAnnals of Neurology, 1998
- NARCOLEPSY1Medicine, 1934